Acer plans to launch the VeriSee DR screening program in the region from the fourth quarter of 2022 to the first quarter of 2023 and will also promote it to other Southeast Asian countries, including the Philippines, Vietnam and India. CONTRIBUTED POSTER
Acer plans to launch the VeriSee DR screening program in the region from the fourth quarter of 2022 to the first quarter of 2023 and will also promote it to other Southeast Asian countries, including the Philippines, Vietnam and India. CONTRIBUTED POSTER

ACER announces the availability of VeriSee DR, an ophthalmic artificial intelligence (AI)-assisted diagnostic solution for diabetic retinopathy (DR), to promote its early detection in the Philippines and other Southeast Asia (SEA) countries. The program consists of three-month free use of VeriSee DR as well as Acer antimicrobial keyboard mouse sets to enable hospitals and clinics to conduct screening tests more efficiently. With the rise of diabetic patients, Acer hopes that by making screening more accessible, it can help detect high-risk cases and contribute to early diagnosis and treatment for DR patients.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details